ATTILLAPS HOLDINGS has a total of 18 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets pharmaceuticals, basic materials chemistry and medical technology are HOAG GEORGE EDWARD, SHANGHAI ZHONGHUA PHARMACEUTICAL CO LTD and JINAN HAOZE ENVIRONMENTAL PROT TECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | South Africa | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Basic materials chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Preservation of human bodies | |
#3 | Therapeutic chemical compounds | |
#4 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Spallitta Frank Anthony | 14 |
#2 | Frank Anthony Spallitta | 2 |
#3 | Spallitta Frank | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019136221A1 | Treating autoimmune disorders with chloroquine and/or hydroxychloroquine | |
WO2019136225A1 | Treating dermatological conditions with chloroquine and/or hydroxychloroquine | |
WO2019126541A1 | Treatment of ophthalmological conditions with acetylcholinesterase inhibitors | |
WO2015195928A1 | Acetylcholinesterase inhibitors for treatment of dermatological conditions | |
AU2014296454A1 | Organophosphates for treating afflictions of the skin |